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Background: Cardiovascular magnetic resonance (CMR) is the current gold standard for the assessment of left
ventricular (LV) function. Repeated breath-holds are needed for standard multi-slice 2D cine steady-state free
precession sequences (M2D-SSFP). Accelerated single breath-hold techniques suffer from low contrast between
blood pool and myocardium. In this study an intravascular contrast agent was prospectively compared to an
extravascular contrast agent for the assessment of LV function using a single-breath-hold 3D-whole-heart cine SSFP
sequence (3D-SSFP).
Methods: LV function was assessed in fourteen patients on a 1.5 T MR-scanner (Philips Healthcare) using
32-channel coil technology. Patients were investigated twice using a 3D-SSFP sequence (acquisition time 18–25 s)
after Gadopentetate dimeglumine (GdD, day 1) and Gadofosveset trisodium (GdT, day 2) administration. Image
acquisition was accelerated using sensitivity encoding in both phase encoding directions (4xSENSE). CNR and BMC
were both measured between blood and myocardium. The CNR incorporated noise measurements, while the BMC
represented the coeffiancy between the signal from blood and myocardium [1]. Contrast to noise ratio (CNR),
blood to myocardium contrast (BMC), image quality, LV functional parameters and intra-/interobserver variability
were compared. A M2D-SSFP sequence was used as a reference standard on both days.
Results: All 3D-SSFP sequences were successfully acquired within one breath-hold after GdD and GdT
administration. CNR and BMC were significantly (p < 0.05) higher using GdT compared to GdD, resulting in an
improved endocardial definition. Using 3D-SSFP with GdT, Bland–Altman plots showed a smaller bias (95%
confidence interval LVEF: 9.0 vs. 23.7) and regression analysis showed a stronger correlation to the reference
standard (R2 = 0.92 vs. R2 = 0.71), compared to 3D-SSFP with GdD.
Conclusions: A single-breath-hold 3D-whole-heart cine SSFP sequence in combination with 32-channel technology
and an intravascular contrast agent allows for the accurate and fast assessment of LV function.
Trial registration: The study was approved by the local research ethics committee (Study No. 07/Q0704/2) and
was registered with the Medicines and Healthcare Products Regulatory Agency (MHRA Study No. 28482/0002/001–0001,
EudraCTnumber 2006–007042).
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The assessment of left ventricular (LV) volumes and func-
tion is of high importance in patients with cardiovascular
disease as it has therapeutic and prognostic consequences
[1]. Cardiovascular magnetic resonance (CMR) is the gold
standard method for the assessment of cardiac function
and regional wall motion [1-3]. Currently used CMR tech-
niques require the acquisition of multiple short-axis slices
during repeated breath-holds to cover the ventricles from
base to apex. For severely ill or non-compliant patients,
performing multiple breath-holds can be challenging.
Additionally, spatial misalignment of slices can occur if
patients do not fully comply with breathing commands. A
single breath-hold technique allowing the accurate assess-
ment of cardiac volumes and function would significantly
reduce scan time and increase patient comfort.
Recently, 3D time resolved cine steady-state-free pre-
cession (SSFP) sequences using sensitivity encoding
(SENSE) undersampling were introduced for ventricular
functional assessment within a single breath-hold [4].
Other available approaches to accelerate image acquisition
include parallel imaging [5] and undersampled reconstruc-
tion kt-techniques [6,7]. All these time-accelerated acqui-
sition techniques suffer from a reduction in blood to
myocardium contrast, compared to standard multi-slice
(M2D) sequences with repeated breath-holds. The
reduced blood to myocardium contrast results from lim-
ited inflow of blood into the acquisition volume, which
covers the complete ventricle [1]. This reduced contrast
can hamper a clear delineation of endocardial borders,
which is necessary for the precise assessment of left ven-
tricular volumes and function.
A recent study indicated, that the administration of an
extravascular contrast agent immediately prior to image
acquisition results in an increase in blood to myocar-
dium contrast using a 3D-SSFP sequence [8]. Extravascu-
lar contrast agents rapidly redistribute into extravascular
tissues, thereby limiting the contrast between myocardium
and blood. Additionally, this type of contrast agent has a
5- to 6-fold lower R1 relaxivity at 1.5 T compared to novel
intravascular contrast agents [9].
In this study, the following hypothesis was tested: The
administration of an intravascular contrast agent in
combination with a single-breath-hold 3D-whole-heart
cine SSFP sequence using a 32-channel cardiac coil and
SENSE undersampling allows a more accurate assess-
ment of the left ventricular function compared to an
extravascular contrast agent.
Methods
Study population and design
Fourteen patients with congenital heart disease (age: 23 to
43 years; median: 36 years) were prospectively enrolled
into this study. All patients were in sinus rhythm. Writteninformed consent was obtained from all patients. The
study was approved by the institutional review board (IRB
No. 07/Q0704/2) and was registered with the Medicines
and Healthcare Products Regulatory Agency (MHRA
Study No. 28482/0002/001-0001, EudraCT number 2006–
007042). Only individuals without contraindications to
CMR and MR contrast agents were included in this study.
Any suspicion of kidney impairment resulted in exclusion
from the study. Patients were given a take-home informed
consent regarding MR contrast media.
The imaging protocol of this study was designed to pro-
vide an intra-individual evaluation of functional left ven-
tricular parameters. The same patient was investigated
twice. On day 1, Gadopentetate dimeglumine (GdD, Mag-
nevistW, Bayer Schering Pharma AG, Berlin, Germany;
max. 0.2 mmol/kg; max. volume 40 ml) and on day 2
(> 24 hours but within 6 days after administration of GdD)
Gadofosveset trisodium (GdT, VasovistW, Bayer Schering
Pharma AG, 0.03 mmol/kg) was injected. The contrast
agents were given as part of a first-pass MR angiogram
and a subsequent cardiac evaluation, which was clinically
indicated. All examinations were performed on a 1.5 T
clinical MR scanner (Achieva, Philips Healthcare, Best,
Netherlands) equipped with a 32-element cardiac coil (16
anterior and 16 posterior elements). After localization and
coil sensitivity reference scans, an interactive scan was
used to determine the geometry of the short axis view.
Based on these images, planning of standard multi-slice
cine 2D SSFP sequences (M2D-SSFP) and single-breath-
hold 3D-whole-heart cine SSFP sequence (3D-SSFP) was
performed. In all patients, 3D-SSFP sequences were per-
formed between 3–9 minutes after the administration of
the respective contrast agent (GdT or GdD). In a subgroup
of patients standard M2D-SSFP, associated with multiple
breath-holds, was performed for volumetric and functional
ventricular assessment (n = 8). M2D-SSFP scans were per-
formed on both days for each patient prior to the adminis-
tration of the respective contrast agent. Respective
imaging parameters for M2D and 3D sequences: Flip angle
(degree) 60, 60; TR/TE 1.6/3.2, 1.8/3.5; Field of view (mm)
340x340, 340x340; Spatial resolution (mm) 1.4x1.4,
1.45x1.45; Slice thickness (mm) 10, 10; Number of slices
10–12, 10–12; Number of breath-holds 5–6, 1; Breath-
hold duration (s) 11–18, 18–25; Acceleration factor
(SENSE acquisition) 2 (AP), 4 (2 AP x 2 RL); Cardiac
Phases 20, 15. The 3D cine b-SSFP acquisition (3D SSFP)
was accelerated using a SENSE factor of 2 in both phase-
encoding directions (anterior posterior [AP] being the first
phase-encoding direction, and feet-head [FH] being the
second phase-encoding direction) and partial Fourier re-
construction (factor of 0.62) in the first phase-encoding
direction. Furthermore 75% of the cardiac phases were
acquired (i.e. 15 phases), which were interpolated to 20
phases. This results in an overall acceleration factor of 8.6.
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tively (Figure 1).
Image analysis
Image processing was performed using commercially
available analysis software (View Forum, Philips Health-
care, Best, The Netherlands). Image data were assessed
qualitatively (Figure 2) and quantitatively (Figure 3 and
Table 1).
Qualitative image analysis
Consensus reading was performed for image quality
scoring by 2 readers (G.F.G, A.B., >10 and >5 years ex-
perience in cardiac MR). Prior to the analysis, a trial as-
sessment of 5 separate CMR images of all MR sequences
for quality assurance was performed. Subsequently, the
two readers analyzed all images independently in a
blinded and random order. Disagreements were dis-
cussed before a final single grade was given. The image
grading system was adopted from McConnell et al.
(Table 2) [10].
Quantitative image analysis
Mean signal intensities (S) of the myocardium and blood
pool were measured at end diastole. For assessment of
the signal of the myocardium the region of interest
(ROI) was placed in the septal myocardium of the mid-
ventricle. The signal of blood was defined as the mean
signal from a ROI drawn in the center of the left ven-
tricle at enddiastole, excluding the papillary muscles.
Noise (N) was determined by the standard deviation in
the respective ROIs, as parallel imaging was used
(SENSE) [11]. The noise (N) for all measurements wasFigure 1 Representative examples of the left-ventricular mid-portion
B2, B4) for standard multi-slice 2D cine SSFP sequences (M2D-SSFP).
CMR after administration of GdD (A3, A4) and GdT (B3, B4). GdD, Gadopentdetermined by the standard deviation in the respective
ROIs, as parallel imaging (SENSE) was used.
The contrast between blood pool and myocardium




CNR was defined as described in the following equa-
tion [13]:
CNR
¼ SMeanBlood  SMeanMyocardium
0:5  NMeanBlood þ NMeanMyocardium
 
Ventricular volume analysis
Volumes derived from single-breath-hold 3D-whole-
heart cine SSFP sequences (3D-SSFP) after the adminis-
tration of GdD and GdT for the evaluation of LV
volumes were compared to volumes derived from stand-
ard multi-slice 2D cine SSFP sequences (M2D-SSFP,
reference standard). In a subgroup of patients standard
M2D-SSFP, associated with multiple breath-holds, was
performed for volumetric and functional ventricular as-
sessment (n = 8). M2D-SSFP scans were performed on
both days in each patient prior to the administration of
the respective contrast agent. We included this group, to
intra-individually compare M2D-SSFP (as clinical refer-
ence standard) to 3D-SSFP scans regarding ventricular
function. The four chamber view was used to plan the
short-axis stack. The most basal slice was defined when
at least 50% of the LV myocardial circumference was vis-
ible at end-diastolic and end-systolic short axis slices.
The end-diastole and end-systole were defined as thein end-diastolic (A1, A3, B1, B3) and end-systolic phase (A2, A4,
Examples of single-breath-hold 3D-whole-heart cine SSFP (3D-SSFP)
etate dimeglumine; GdT, Gadofosveset trisodium.
Figure 2 Image quality for standard multi-slice 2D cine SSFP
(M2D-SSFP) and single-breath-hold 3D-whole-heart cine SSFP
(3D-SSFP) sequences. Image quality was significantly (p < 0.05)
higher using GdT compared to GdD. GdD, Gadopentetate
dimeglumine; GdT, Gadofosveset trisodium.
Table 1 Left Ventricular Functional Parameters
Day 1 Day 2
M2D-SSFP 3D-SSFP+GdD M2D-SSFP 3D-SSFP+GdT
ED volume (ml) 147.2±29.9 145.0±39.0 140.2±22.1 143.6±17.6
ES volume (ml) 57.9±19.1 65.6±27.4 59.6±14.4 61.2±11.8
Ejection fraction
(%)
60.9±8.6 56.0±11.0 57.7±7.2 57.5±5.8
Left ventricular functional parameters for standard multi-slice 2D cine SSFP
(M2D-SSFP) and single-breath-hold 3D-whole-heart cine SSFP (3D-SSFP)
sequences. No significant differences (P > 0.05) were found between volume
and EF on same day. Values are given as mean ± standard deviation. ED, end
diastolic; ES, end systolic; GdD, Gadopentetate dimeglumine; GdT,
Gadofosveset trisodium.
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showed the largest and smallest LV cavity area. Papillary
muscles were excluded from the analysis of the ventricu-
lar volume [12]. Measurements were performed by
MRM and GFG. Left ventricular volume and ejection
fraction were compared between both methods
(Table 1).
For interobserver variability two independent obser-
vers analyzed 8 of the datasets. For intraobserver vari-
ability the same datasets were evaluated twice by the
same observer. Datasets were used for the analysis of
intraobserver and interobserver variability were ran-
domly chosen for both analysis.
Statistics
Continuous variables are reported as mean± standard devi-
ation. Paired and unpaired t-testing was used to compare
continuous variables, as appropriate. The agreement be-
tween observers regarding image quality grading was
assessed by the Wilcoxon signed rank test. A p-value <0.05Figure 3 Blood to myocardium contrast (BMC, A) and contrast to nois
and single-breath-hold 3D-whole-heart cine SSFP (3D-SSFP) sequence
compared to GdD.was considered statistically significant. Linear regression
analysis was used to assess the volumetric agreement of
3D-SSFP with M2D-SSFP sequences. Bland–Altman ana-
lysis was used to assess differences and bias [14].Results
Fourteen patients were enrolled into the study protocol.
No side effects were correlated to the use of either con-
trast agent (> 1 year follow-up). There was no significant
(p > 0.05) difference in heart rate between the first and
second scan session.Qualitative image analysis
Image quality of single-breath-hold 3D-whole-heart cine
SSFP sequence (3D-SSFP) after the administration of
GdD and GdT were compared (Figure 1). GdT improved
image quality significantly (p < 0.05) in 3D-SSFP scans
compared to GdD (Figure 2).Quantitative image analysis
Results from the blood to myocardial contrast analysis
(BMC) and contrast to noise ratios (CNR) are shown in
Figure 3. After GdT administration, single-breath-hold
3D-whole-heart cine SSFP (3D-SSFP) images demon-
strated a significantly (p < 0.05) higher BMC and CNRe ratio (CNR, B) for standard multi-slice 2D cine SSFP (M2D-SSFP)
s. BMC and CNR were significantly (p < 0.05) higher using GdT
Table 2 Image quality scoring system
Score Description
1 Poor-image quality: non diagnostic
2 Endocardial border barely or not delineable
3 Endocardial border moderately or partly delineable
4 Endocardial border well delineable
5 Endocardial border excellently delineable
Image quality scoring system adapted from McConnell et al [10].
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(Figure 3).
Left ventricular volume analysis
Left ventricular parameters for all scan groups are
shown in Table 1. No significant difference between the
M2D-SSFP and respective single-breath-hold 3D-whole-
heart cine SSFP sequence (3D-SSFP) scans on the same
day were measured for LVEDV, LVESV and LVEF.
Using 3D-SSFP with GdT, Bland–Altman plots showed
a smaller bias (95% confidence intervals LVEF: 9.0 vs.
23.7) and a regression analysis showed a stronger correl-
ation with M2D-SSFP as the reference standard
(R2 = 0.92 vs. R2 = 0.71), compared to 3D-SSFP with GdD
(Figure 4, 5). 95% confidence intervals and means of
intra- and interobserver variability are shown in Tables 3Figure 4 Bland-Altman plots demonstrating the agreement between
hold 3D-whole-heart cine SSFP (3D-SSFP) sequences after the admini
assessment of LV end-diastolic volume (LVEDV; A1, 2), LV end-systolic
Altman plots show a relatively high bias and regression analysis show a mo
reference standard. Dashed lines equal the 95% limits of agreement. Bias (sand 4. For intra- and interobserver variability no statis-
tical differences was found comparing the mean func-
tional values (LVEF, LVEDV, LVESV) for 3D-SSFP data
with M2D-SSFP reference data, confirming the reprodu-
cibility of these techniques.
Imaging time
Scan time for single-breath-hold 3D-whole-heart cine
SSFP sequences (3D-SSFP) was significantly shorter
compared to M2D-SSFP sequences (18-25 s vs. 4–5
mins, p < 0.05).
Discussion
In this prospective study, the administration of an intra-
vascular contrast agent in combination with a single-
breath-hold 3D-whole-heart cine SSFP sequence (3D-
SSFP) improved image quality significantly. This resulted
in a more accurate assessment of LV function compared
to the use of an extravascular contrast agent. The use of
32-channel-coil technology and a SENSE factor of 4,
enabled imaging with a temporal and spatial resolution
comparable to standard multi-slice 2D cine SSFP
sequences (M2D-SSFP) [11]. The use of GdT improved
the delineation of left ventricular endocardial borders
and enabled the accurate quantification of LV volumes
and function within one breath-hold. The higher CNRstandard multi-slice 2D cine SSFP (M2D-SSFP) and single-breath-
stration of Gadopentetate dimeglumine (GdD) with regard to the
volume (LVESV; A3, 4), LV ejection fraction (LVEF; A5, 6). Bland–
derate correlation using 3D-SSFP with GdD compared to M2D-SSFP as
olid line) equals mean difference between techniques.
Figure 5 Bland-Altman plots demonstrating the agreement between standard multi-slice 2D cine SSFP (M2D-SSFP) and single-breath-
hold 3D-whole-heart cine SSFP (3D-SSFP) sequences after the administration of Gadofosveset trisodium (GdT) with regard to the
assessment of LV end-diastolic volume (LVEDV; A1, 2), LV end-systolic volume (LVESV; A3, 4), LV ejection fraction (LVEF; A5, 6). Bland–
Altman plots show a small bias and regression analysis shows a strong correlation using 3D-SSFP with GdT compared to M2D-SSFP as reference
standard. Dashed lines equal the 95% limits of agreement. Bias (solid line) equals mean difference between techniques.
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resulted from the higher relaxivity of the contrast agent
and its prolonged intravascular half life, compared to the
extravascular contrast agent used [15-23]. This study
demonstrated that 3D assessment of ventricular function
with high accuracy is feasible in a significantly shortened
imaging time. Severely ill patients may particularly benefit
from shorter scans times, while scanning costs are reduced.
Gadofosveset trisodium reversibly binds to serum albu-
min with a binding fraction of approximately 85% and
therefore predominately remains in the blood pool. High
contrast imaging was shown to be feasible up to 60 min
after contrast agent administration [15]. The binding toTable 3 Intraobserver Variability
95% Confidence interval (ml) Mean difference
LVEDV (ml) LVESV (ml) LVEF (%) LVEDV LVESV LVEF
M2D-SSFP [−7.1; 9.3] [−9.5; 9.5] [−6.6; 6.2] 1.1 0.03 −0.2
3D-SSFP+GdD [−10.2; 8.7] [−13.8; 11.3] [−9.2; 9.7] −0.7 −1.3 0.3
M2D-SSFP [−7.1; 6.3] [−6.2; 4.6] [−5.0; 5.7] −0.4 −0.8 0.3
3D-SSFP+GdT [−6.3; 8.4] [−10.7; 10.3] [−6.6; 7.7] 1.1 −0.2 0.5
Intraobserver variability for standard multi-slice 2D cine SSFP (M2D-SSFP) and
single-breath-hold 3D-whole-heart cine SSFP (3D-SSFP) sequences. 95%
Confidence intervals for 3D-SSFP +GdT were narrower compared to 3D-
SSFP +GdD. ED, end diastolic; ES, end systolic; GdD, Gadopentetate
dimeglumine; GdT, Gadofosveset trisodium.albumin lowers the rate of molecular tumbling of the gado-
linium, resulting in a better rotational correlation with
water protons. This yields a 5- to 6-fold greater R1 relaxiv-
ity at 1.5 T compared with conventional gadolinium con-
trast agents [9]. With regard to NSF, no cases have been
associated with the use of gadofosveset trisodium so far.
Due to the greater relaxivity, gadofosveset can be adminis-
tered at a 3-fold lower dose, while providing greater en-
hancement from the ventricular blood pool. The usefulness
of intravascular contrast agents for the assessment of 3D
vascular structures has already been demonstrated [24,25].
A recently published study focused on the direct com-
parison of non-contrast-enhanced 2D-SSFP sequences vs.Table 4 Interobserver Variability
95% Confidence interval Mean difference
LVEDV (ml) LVESV (ml) LVEF (%) LVEDVLVESVLVEF
M2D-SSFP+GdD [−14.9; 12.4] [−12.0; 9.0] [−5.1; 5.9] −1.3 −1.5 0.4
3D-SSFP+GdD [−19.4; 21.7] [−14.2; 12.1] [−9.2; 12.5] 1.2 −1.1 1.6
M2D-SSFP+GdT [−9.3; 10.8] [−9.2; 8.3] [−6.7; 7.9] 0.7 −0.4 0.6
3D-SSFP+GdT [−7.9; 12.5] [−13.2; 10.5] [−8.8; 11.3] 2.3 −1.4 1.2
Interobserver variability for standard multi-slice 2D cine SSFP (M2D-SSFP) and
single-breath-hold 3D-whole-heart cine SSFP (3D-SSFP) sequences. 95%
Confidence intervals for 3D-SSFP +GdT were narrower compared to 3D-
SSFP +GdD. ED, end diastolic; ES, end systolic; GdD, Gadopentetate
dimeglumine; GdT, Gadofosveset trisodium.
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dimeglumine enhanced 3D acquisitions [5]. This study
demonstrated that the CNR between blood and myocar-
dium in 3D acquisitions increases directly after the admin-
istration of an extravascular contrast agent.
The administered contrast agents would also have had
an effect on gradient echo (GRE) sequences. GRE profits
from shortening the T1-relaxtion time of blood. In par-
ticular, GRE is often used to study myocardial function
at higher field strength (e.g. 3 Tesla). However, a high
blood contrast with GRE is only possible through in-
flow enhancement in 2D imaging or after administration
of a contrast agent. In spoiled GRE the image contrast is
proportional to sqrt(TR/2 T1) for the optimal flip-angle
and thus profits from shortening T1. However, even for
a short T1 relaxation time the overall signal is usually
lower than in SSFP imaging, in which case the contrast
is proportional to 0.5*sqrt(T2/T1) resulting in a rela-
tively high signal and thus SNR. Although a contrast
agent is shortening both the T1 and T2 relaxation time,
the T1 effect is usually higher. Therefore, in SSFP a sig-
nal increase can also be found after contrast agent ad-
ministration. The signal enhancement can be calculated
for a tissue (e.g. blood) for a given contrast agent con-
centration (assuming the T1 of the blood reduces from
1400 ms to 220 ms). In spoiled GRE the blood signal
would increase from 0.035 to 0.09. In SSFP the blood
signal would increase from 0.22 to 0.4 (taking also the
small T2 shortening into account). Although the relative
signal increase is larger in GRE the overall signal ampli-
tude is higher in SSFP imaging resulting in a higher SNR
of SSFP in comparison to GRE.
Other potential applications of 3D techniques include
pharmacological stress MRI scans of the myocardium.
Traditionally, three short axis slices with intra-slice gaps
are planned through the LV [26]. Each slice has to be
acquired within a separate breath-hold during stress
conditions. A 3D approach may offer an attractive alter-
native, as it is a fast acquisition method, which allows
covering both ventricles within one breath-hold with
high temporal resolution. The administration of an
intravascular contrast agent may be beneficial, as a
clearer delineation of the endocardial border is possible,
which is especially important for the assessment of re-
gional wall motion. Its use for myocardial perfusion
stress testing is currently under investigation.
In this study we could demonstrate, that the single
breath-hold assessment of cardiac function using a
highly accelerated 3D single breath-hold acquisition
technique in combination with a low dose (0.03 mmol/
kg) of an intravascular contrast agent allows for the ac-
curate and fast assessment of LV function.Conclusion
In conclusion, the use of a 3D-whole-heart cine SSFP se-
quence in combination with 32-channel technology and
an intravascular contrast agent allows for the accurate and
fast assessment of LV function within a single breath-hold.
Study limitations
No conclusion from our data is applicable to patients
with arrhythmia. It is also important to note that the
volumetric data were acquired at different time points
during separate CMR examinations in a resting patient,
which may cause slight changes in ventricular volumes.
As this technique relies on contrast enhancement after
the administration of a contrast agent, it is not applic-
able in patients with renal impairment. The role of intra-
vascular contrast agents for imaging myocardial delayed
enhancement is subject to on-going investigations and
has not been addressed in the current study. In case in-
formation on myocardial scar imaging is relevant, gado-
pentetate dimeglumine may be the preferred contrast
agent at the moment. However, improved cardiovascular
imaging can be provided additional to faster functional
assessment of the LV using intravascular contrast agents,
which may be very useful in patients with congenital
heart disease. Significant flow artifacts in the ventricles
were not observed in our patient population during the
cardiac cycle as none of our patients had abnormal in-
flow or outflow of the cardiac chambers.
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